IgA nephropathy: open trials in Croatia

2 open trials have a site in Croatia. Registry data; only the trial team decides who can take part.

2024-519638-22-00
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
Trial Treatment · Phase 3 · Novartis Pharma AG
Specijalna Bolnica Medico, Rijeka · Poliklinika Bonifarm, Zagreb
Registry updated 2026-10-30
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Trial Treatment · Phase 3 · Biogen
Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb · Poliklinika BONIFARM, Grad Zagreb · Specijalna Bolnica Medico, Rijeka · Clinical Hospital Centre Rijeka, Rijeka
Registry updated 2026-10-14

This page is not medical advice. Talk to your doctor before contacting a trial.

A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials